Qube Research & Technologies (QRT)
MBRX icon

Qube Research & Technologies (QRT)’s Moleculin Biotech MBRX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MBRX Stock Details MBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-59
Closed -$105K – 2211
2020
Q4 		$105K Sell
59
-101
-63% -$179K ﹤0.01% 1640
2020
Q3 		$293K Buy
160
+131
+452% +$278K ﹤0.01% 1255
2020
Q2 		$62K Buy
+29
New +$68.8K ﹤0.01% 1573

Other funds holding MBRX

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MBRX Position: Q1 2021 in Review

Qube Research & Technologies (QRT) sold out of Moleculin Biotech (MBRX) in Q1 2021, closing a stake of 59 shares — an estimated $105K sold.

Qube Research & Technologies (QRT) first reported a position in MBRX in Q2 2020 and held it in 3 quarters. The position peaked at $293K in Q3 2020. 27 funds tracked by Wall St. Rank hold MBRX as of Q1 2021.

  • Qube Research & Technologies (QRT) reported no remaining Moleculin Biotech position as of Q1 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 59 Moleculin Biotech shares in Q1 2021, an estimated $105K.
  • Qube Research & Technologies (QRT) first reported a position in Moleculin Biotech in Q2 2020 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Moleculin Biotech position peaked at $293K in Q3 2020.
  • 27 funds tracked by Wall St. Rank held Moleculin Biotech as of Q1 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2021, filed 14 May 2021.